Antiproliferative effects of boswellic acids-loaded chitosan nanoparticles on human lung cancer cell line A549.
- Future Science
- Publication Type:
- Journal Article
- Future Medicinal Chemistry, 2020, 12, (22), pp. 2019-2034
- Issue Date:
|Antiproliferative effects of boswellic acid-loaded chitosan nanoparticles on human lung cancer cell line A549.pdf||Published version||2.82 MB|
Copyright Clearance Process
- Recently Added
- In Progress
- Closed Access
This item is closed access and not available.
Aim: In the present study boswellic acids-loaded chitosan nanoparticles were synthesized using ionic gelation technique. The influence of independent variables were studied and optimized on dependent variables using central composite design. Methodology/results: The designed nanoparticles were observed spherical in shape with an average size of 67.5-187.2 nm and have also shown an excellent entrapment efficiency (80.06 ± 0.48). The cytotoxicity assay revealed enhanced cytotoxicity for drug-loaded nanoparticles in contrast to the free drug having an IC50 value of 17.29 and 29.59 μM, respectively. Flow cytometry confirmed that treatment of cells with 40 μg/ml had arrested 22.75 ± 0.3% at SubG0 phase of the cell cycle when compared with untreated A459 cells. The observed results justified the boswellic acids-loaded chitosan nanoparticles were effective due to greater cellular uptake, sustained intercellular drug retention and enhanced antiproliferative effect by inducing apoptosis.
Please use this identifier to cite or link to this item: